# Reproductive history and cardiometabolic disease: the role of endogenous estrogen exposure across the lifespan in postmenopausal women

**Authors:** Yingze Zhu, Jialu Li, Wenjing Qin, Liang Wang, Qi Qi, Shaoru Li, Yue Cheng, Yuan Shen, Wenfang Yang, Zhonghai Zhu, Lingxia Zeng

PMC · DOI: 10.1186/s12905-025-04030-5 · BMC Women's Health · 2025-10-21

## TL;DR

The study finds that longer exposure to natural estrogen in women's reproductive years is linked to lower risks of heart and metabolic diseases, while more pregnancies are linked to higher risks.

## Contribution

This study identifies specific reproductive history factors as potential indicators for cardiometabolic disease risk in postmenopausal women.

## Key findings

- Each additional year of reproductive lifespan was associated with lower risks of diabetes, hypertension, and CVD.
- Higher gestation-to-reproductive lifespan ratio increased risks of cardiometabolic diseases.
- Multiple pregnancies were linked to elevated risks of hypertension and CVD.

## Abstract

The association between cumulative endogenous estrogen exposure across the lifespan, especially considering reproductive events, and women’s cardiometabolic health remain unclear. We aimed to examine the associations between lifetime endogenous estrogen exposure and the risks of diabetes, hypertension, and cardiovascular disease (CVD) among postmenopausal women.

We used baseline data from the Regional Ethnic Cohort Study in Northwest China. Reproductive factors were self-reported using a structured questionnaire, and surrogate indicators of estrogen exposures—reproductive lifespan, endogenous estrogen exposure, cumulative gestation duration and other proportional indicators—were calculated. Diabetes, hypertension and CVD were defined based on self-reported physician diagnoses at the hospital. Multivariable logistic regression models were employed to estimate adjusted odds rations (aORs) and 95% confidence intervals (CIs).

Among 35,498 postmenopausal women (median age 59.0 years [interquartile range: 54.0–65.0], each additional year of reproductive lifespan was associated with lower risks of diabetes (aOR 0.971; 95%CI 0.961, 0.982), hypertension (aOR 0.969; 95%CI 0.962, 0.975) and CVD (aOR 0.954; 95%CI 0.946, 0.962). Similar inverse associations were observed for endogenous estrogen exposure. In contrast, a higher ratio of gestation-to-reproductive lifespan duration was positively associated with increased risks of diabetes, hypertension, and CVD. Multiple incomplete pregnancies were associated with increased diabetes risk, while multiple complete pregnancies were linked to elevated risks of hypertension and CVD.

Longer exposure to endogenous estrogen was associated with decreased risk of cardiometabolic disease, while a higher burden of gestational events was associated with increased risks. Reproductive history could be considered as an indicator for risk stratification and management of cardiometabolic disease in women.

The online version contains supplementary material available at 10.1186/s12905-025-04030-5.

## Linked entities

- **Diseases:** diabetes (MONDO:0005015), cardiovascular disease (MONDO:0004995)

## Full-text entities

- **Diseases:** Diabetes (MESH:D003920), cardiometabolic disease (MESH:D024821), hypertension (MESH:D006973), CVD (MESH:D002318)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12538824/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12538824/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12538824/full.md

---
Source: https://tomesphere.com/paper/PMC12538824